Transcode Therapeutics, Inc. (RNAZ) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $6.7K | -69.4% |
| 2024 | $21.8K | -38.9% |
| 2023 | $35.6K | -64.7% |
| 2022 | $100.9K | -60.4% |
| 2021 | $254.8K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $6.7K | -69.4% |
| 2024 | $21.8K | -38.9% |
| 2023 | $35.6K | -64.7% |
| 2022 | $100.9K | -60.4% |
| 2021 | $254.8K | — |